Significance A Busy Clinician's Guide to Seniors with Memory Loss

Similar documents
If a bad thing is happening to a patient, a drug did it until proven otherwise

Understanding Dementia

Memory Loss, Dementia and Alzheimer's Disease: The Basics

4/11/2017. The impact of Alzheimer s disease. Typical changes. The impact of Alzheimer s disease. Problematic changes. Problematic changes

Literature Scan: Alzheimer s Drugs

Diagnosis and Treatment of Alzhiemer s Disease

The Basics of Alzheimer s Disease

Dementia is not normal aging!

3/6/2019 DIAGNOSIS OF DEMENTIA IN THE OUTPATIENT SETTING FINANCIAL DISCLOSURES LEARNING OBJECTIVES

Dementia NICE Guidelines Update. Key points for primary care - NICE guideline (June 2018 update ) 26 September 2018

Identification of Cognitive Impairment in HIV patients. Belinda Vicioso MD FACP, AGSF Jose Garcia Professor of Medicine UTSW

As a general cognitive screening tool or as part of an annual exam (Medicare Annual Wellness Visit).

Forgetfulness: Knowing When to Ask for Help

Drug Update. Treatments for Cognitive Impairment in the Older Adult. William Solan, M.D. Karen Sanders, Ph.D. Northwest Hospital Seattle

Dementia and Fall Geriatric Interprofessional Training. Wael Hamade, MD, FAAFP

EARLY DEMENTIA. University of Hawaii Geriatric Medicine Department

Active Learning Strategies for Mastering Geriatric Assessment Tools

Dementia Basics. Welcome! What to expect and how to handle a dementia diagnosis. In partnership with Scripps Health.

Dr. Michael Lobatz Dr. Michael Jackson Dr. James Brewer Dr. Paul Aisen. Dr. Michael Plopper. Dr. Guerry Peavy

Evaluations & CE Credits

Recognizing Signs and Symptoms of Alzheimer's Disease in Earlier Stages Can Lead to Diagnosis

Objectives. Prevalence of AD by age. Diagnosing and Managing Dementia in Ambulatory Practice

Dementia and Primary Care. A Structured Team Approach UNE/MGEC Conference June 2014

Information Gathering Obtaining history is the most critical first step Patient-provided history may not be reliable Need info from relatives, friends

Resident Assessment Best Practices M E G A N M. G R A E S E R, D N P, G N P - BC P H Y S I C I A N H O U S E C A L L S, L L C

Delirium Pilot Project

Treatments for Alzheimer s Disease A Quick Guide for Patients and Caregivers

DEMENTIA? 45 Million. What is. WHAT IS DEMENTIA Dementia is a disturbance in a group of mental processes including: 70% Dementia is not a disease

The Gnosall Model for dementia Dr Ian Greaves

Beyond memory loss. March 5, Alzheimer s Overview. In partnership with. Mary Ball President & CEO

Dementia ALI ABBAS ASGHAR-ALI, MD STAFF PSYCHIATRIST MICHAEL E. DEBAKEY VA MEDICAL CENTER ASSOCIATE PROFESSOR BAYLOR COLLEGE OF MEDICINE

Evaluation and Treatment of Dementia

Michael A. Lobatz MD The Neurology Center Scripps Rehabilitation Center

Delirium. A Geriatric Syndrome. Jonathan McCaleb, MD, CMD, HMDC UNSOM, Assistant Professor of Medicine Geriatrics / Hospice & Palliative Medicine

ALZHEIMER S DISEASE OVERVIEW. Jeffrey Cummings, MD, ScD Cleveland Clinic Lou Ruvo Center for Brain Health

WHAT IS DEMENTIA? An acquired syndrome of decline in memory and other cognitive functions sufficient to affect daily life in an alert patient

Alzheimer Disease Agents Drug Class Prior Authorization Protocol

Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist

Dr. W. Dalziel Professor, Geriatric Medicine Ottawa Hospital. November /20/ Safety: Falls/Cooking/Unsafe Behaviour. 2.

Dementia. Memory Evaluation Center Neurology

ALZHEIMER S DISEASE. Mary-Letitia Timiras M.D. Overlook Hospital Summit, New Jersey

AGED SPECIFIC ASSESSMENT TOOLS. Anna Ciotta Senior Clinical Neuropsychologist Peninsula Mental Health Services

RCFE ADMINISTRATOR INITIAL CERTIFICATION PROGRAM

Raj C. Shah, MD Associate Professor in Family Medicine Rush Alzheimer s Disease Center Rush University Medical Center

Screening Summary (SS2)

Alzheimer's disease (AD), also known as Senile Dementia of the Alzheimer Type (SDAT) or simply Alzheimer s is the most common form of dementia.

Disclosure. Speaker Bureaus. Grant Support. Pfizer Forest Norvartis. Pan American Health Organization/WHO NIA HRSA

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health Technology Appraisal

Alzheimer s Disease. Fact Sheet. Fact Sheet. Fact Sheet. What Causes AD?

GERIATRIC MENTAL HEALTH AND MEDICATION TREATMENT

Case Presentation. Cognition: changes with Normal Aging? Synonyms

UNDERSTANDING CAPACITY & DECISION-MAKING VIDEO TRANSCRIPT

Causes of Transient Incontinence. Geriatrics: Urinary Incontinence, Dementia, and Delirium. Classification of Established Incontinence

Cognitive Assessment 4/29/2015. Learning Objectives To be able to:

Medications for Alzheimer s disease: are they right for you?

Alzheimer s Disease 1818 Society World Bank December 4, Raya Elfadel Kheirbek, MD, MPH

Delirium in the hospitalized patient

Objectives. My Patient: The story 10/6/2017

A Geriatrician s Perspective on Successful Aging. Ariel Green, MD, MPH Assistant Professor of Medicine

Introduction to Screening/Assessment Tools for Mood & Cognition

Alzheimer s Disease. Pathophysiology: Alzheimer s disease (AD) is a progressive dementia affecting cognition, behavior,

Learning Goals. Dementia Care Planning: It s A Family Affair. Participants will:

Dementia Facts and Resources Dementia Warning Signs Getting a Diagnosis Dementia Communication Tips Dementia Risk Reduction.

Memory Matters Service Dementia, Depression and Delerium Cancer Awareness Toolkit Evaluation Event

Evaluations. Alzheimer s Disease A Public Health Response. Viewer Call-In. July 19, Guest Speakers. Thanks to our Sponsors:

Cal MediConnect Dementia Awareness CMC Annual Training

Sorting Out the Three D s:

Geriatric Alterations Associated with Neurological Conditions

GERIATRICS 101. Victoria L. Braund, MD, FACP, CMD. Director, Division of Geriatrics, NorthShore Medical Director, Symphony of Evanston

Evaluating Functional Status in Hospitalized Geriatric Patients. UCLA-Santa Monica Geriatric Medicine Didactic Lecture Series

Medications and Non-Pharma Approaches to Treatment. David J. Irwin, MD Penn Frontotemporal Degeneration Center

Dementia A syndrome, not a disease. Mordechai Lavi, MD Geriatric Physician

Understanding Dementia &

The Psychopharmacology of Alzheimer s Disease. Bruce Kaster, MD Instructor in Psychiatry Harvard Medical school

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

Latest Methods to Early Detection for Alzheimer's: Cognitive Assessments and Diagnostic Tools in Practice

EMR DECISION SUPPORT TOOLS FOR ALZHEIMER S AND RELATED DEMENTIAS

Our rapidly aging population means that more and more people will be diagnosed with Alzheimer s and other dementias in the next 20 years.

Caring Sheet #11: Alzheimer s Disease:

Overview of Alzheimer s Disease

Dementia. Assessing Brain Damage. Mental Status Examination

Implementation of a Dementia Screening Tool (Poster)

TYPES & STAGES OF DEMENTIA AND WHAT IT MEANS FOR YOU. Dr John Mark Geiss Geiss MED, Senior Care Physicians June 28, 2017 Sponsored: ActivCare Living

Alzheimer s Disease: Getting the Facts

Caring for a Patient or Family Member with Alzheimer s Disease or Related Dementia

Test your Knowledge: Recognizing Delirium

1/3/2017 DEPRESSION IN THE OLDER PATIENT: EVALUATION AND MANAGEMENT

DEPRESSION IN THE OLDER PATIENT: EVALUATION AND MANAGEMENT

Hospitalization- Associated Disability

From MCI to Dementia DR YU- MIN LIN GERIATRICIAN AUG 2018

A Palliative Approach in Caring for the Person and Family Living with Dementia Hospice and Palliative Nurses Association (HPNA) Online Education

The Annual Wellness Visit for Medicare Beneficiaries/PCP and Care Transitions

The Person: Dementia Basics

Polypharmacy and the Older Adult. Leslie Baker, PharmD, BCGP Umanga Sharma, MD

Strategies for Dementia and Alzheimer s Care. Welcome and Introduction. Thank you, Why this topic? 3/9/2017

Appendix K: Evidence review flow charts

Delirium and Dementia. Summary

DEMENTIA SCREENING AND IMPORTANCE OF INCLUDING CNAS

Dementia: How to explain the diagnosis to patients and relatives

NHS FORTH VALLEY. Assessment Tools for Depression, Cognitive Impairment and Delirium in General Practice

Transcription:

Significance A Busy Clinician's Guide to Seniors with Memory Loss Victoria Braund MD FACP CMD Division of Geriatrics. NorthShore University HealthSystem Alzheimer's disease is the sixth leading cause of death in the United States. More than 5 million Americans are living with the disease In 2013, Alzheimer's will cost the nation $203 billion. This number is expected to rise to $1.2 trillion by 2050. Alzheimer s Disease is the only cause of death among the top 10 without a way to prevent it, cure it, or even slow its progression. Why should we screen for dementia? (actually a complicated question ) 16 14 12 10 8 6 4 2 0 Cases of AD, in millions 2013 2025 2050 USPSTF finds insufficient evidence to recommended routine screening for dementia (update 2013) But clinicians should remain alert to early signs or symptoms of cognitive impairment and evaluate their pts as appropriate Ann Int Med 2013; 159:601-612 www.alz.org Medicare Annual Wellness Visit Effective January 2011 Not commonly used (yet) CMS requires cognitive assessment but does not recommend one specific tool Alzheimer's Ass n recommends a brief structures assessment with Mini-Cog, GPCOG, or MIS (and informant interview if available) www.alz.org/hcps Accessed 12/3/13 The thing to remember with dementia pts Do pts with dementia fail to report their symptoms? FREQUENTLY! Do pts with dementia look impaired? RARELY! Do families think just normal aging? ALL THE TIME! We need to screen all older patients! 1

Why screen? Can t cure it Dementia is a chronic disease like diabetes or heart failure Can t cure those either Early detection can lead to More effective treatment Less isolation and inactivity Family assistance Recognition of driving issues Timely placement Barriers to Performing the Mental Status Exam in the Office Time constraints Lack of confidence in own skills, or tests sensitivity Fear of offending patient by asking mental status questions Limitations of the MMSE AOx3 10-15 minutes to administer Language and cultural content (e.g. no ifs, ands, or buts) Highly educated individuals can score 28/30 or higher and still have dementia Does not assess executive function and so can miss frontotemporal dementia Copywritten! Folstein MF et al, J Psychiatr Res. 1975; 12:189-98. Here is something better: The Mini-Cog! The Mini-Cog is 3 words, a clockdrawing test (CDT), and the 3 word recall test The three words tests memory The CDT tests executive functioning Takes 2-3 minutes Detects mild dementia Less language/culture/education bias Clock Drawing Test Simple but useful Tests both sides of the brain Not dependent on verbal skills Non-threatening to patients 2

Patient Name: DOB: Today s Date Examiner: ENC#: 1. Remember these 3 words:,,. 2. Put the numbers on the clock and set the hands to ten after eleven. 3. Word Recall: 1 2 3 4. CDT: N Abn 5. Interpretation The Mini-Cog Scoring Algorithm Adapted from Borson S, et al. Int J Geriatr Psychiatry. 2000;15:1021-1027 Does the Mini-Cog work? The Mini-Cog was significantly (P < 0.001) better than PCPs in recognizing the early stages of dementia. The Mini-Cog was better (P < 0.01) than PCPs in detecting dementia among minority patients, English as second language, or low levels of education. Mini-Cog s performance ranged from 85% to 100% across the spectrum of dementia diagnoses, possibly because the Mini-Cog includes a screen for executive dysfunction as well as memory. Wanna get fancy? Add Animal Naming Name as many animals as you can in 60 seconds. Animal Naming < 14 in 60 seconds is impaired Wisconsin Alzheimer s Institute (WAI) found a sensitivity of 85% and specificity of 88% for this score Table. Wisconsin Dementia Research Consortium Study Animal Naming Results Diagnostic Group Normal Cognition Alzheimer s Disease Other Dementia Abnormal <14 Normal > 14 12% 88% 85% 15% 85% 15% 3

Truly Disturbing; an 8 yowf The Dementia Workup Physical exam Look at the gait, neuro exam Neuro exam normal in Alz Dis Blood work Thyroid, B12, chemistry panel, UA, CBC CT or MRI (with and without) of the brain Medication review Adherence, OTCs (e.g. diphenhydramine ) Alcohol intake review Sleep Almost always, labs are normal and that is consistent with Alzheimer s Disease Making the Diagnosis of AD! History: Slowly progressive Age is #1 risk factor At age 90, there is a 50:50 change of AD No movement disorders No offending meds When the screening test is abnormal! Further evaluation is needed to make a definitive diagnosis Formal neuropsych testing? Cognitive neurologist? Geriatrics? It takes a village: Social Work Alzheimer s Association www.alz.org Community Resources local Senior Center 4

Pharmacologic Management: Acetylcholinesterase Inhibitors: Donepezil (Aricept ), galantamine (Razadyne ), rivistigmine (Exelon ) All are FDA approved for Alz Dis Rivistigmine is approved for dementia in Parkinson s Use the patch not the pills Memantine (Namenda ) Therapy for mod-severe Alz Dis Can be used as monotherapy or as an addon Relatively few side effects May see some dizziness or increased confusion Decrease dose with renal insufficiency!! These are not curative; only delay disease progression A last resort Primary Care Issues in Patients With Dementia Minimize sensory deprivation Cataract surgery? Hearing aids? Wellness issues Immunizations DEXA scan,? Mammograms Treat intercurrent illnesses, esp. UTI/ CAP Which may present with delirium! Watch weight A marker of nutrition as well as living situation Primary Care Issues in Patients With Dementia Ask about sleep Review sleep hygiene Consider trazodone or melatonin or mirtazapine (Remeron) Ask about incontinence Toileting program Urogyne or urology evaluation Be careful with cholinergic meds! Limited efficacy They are anti-aricept! Caregivers These diseases affect caregivers more than the patients Caregivers tend to be: female (70+%) elderly (spouses) or sandwich generation (daughters, dtrs-in-law) emotionally, financially, physically vulnerable Ask em how they re doing! (Burden Interview) Provide and encourage resources and respite 5

Primary Care Issues in Patients With Dementia, cont d Brown Bag Medication review May be the most important thing you do!! Aim for once daily or BID meds Pill box! A big one? No PM products dry eyes, dry mouth, constipation, urinary retention and confusion Dr Vicki s First Rule of Geriatrics If a bad thing is happening to a patient, a drug did it til proven otherwise Remember, these folks have old kidneys, livers, brains Do the Brown Bag Test! Go through the medicine cabinets Bedside tables Kitchen table Cupboards If you dare, the Purse! Primary Care Issues in Patients With Dementia, cont d Thank you! Plan on seeing these patients every 3-4 months Better than getting BOMBED once a year Have resources in your office Local senior centers alz.org website Adult day care programs Community-based social workers Feel free to contact me for questions! vbraund@northshore.org 6